Rut Meseguer Naturil | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Academic Excellence

Best Researcher Award

Rut Meseguer Naturil
Health Research Institute INCLIVA, Spain

Rut Meseguer
Affiliation Health Research Institute INCLIVA
Country Spain
Documents 2
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0000-0003-4376-5997

Rut Meseguer Naturil is a researcher affiliated with the Health Research Institute INCLIVA in Spain whose documented research output includes work in immunology and translational biomedical science. The available publication record highlights research involving natural killer (NK) cell biology, immunotherapy manufacturing, and therapeutic strategies for severe infectious disease. These contributions provide a basis for consideration within the Best Researcher Award category of the International Academic Excellence Awards.

Abstract

The research record associated with Rut Meseguer Naturil encompasses biomedical investigation relevant to immune-cell biology and translational medicine. A recent publication examines how donor NKG2A/NKG2C immunophenotypes influence the GMP-compliant manufacturing potential of NK cells for adoptive immunotherapy, connecting donor characteristics with the practical development of cellular therapeutic products [1]. Earlier work addressed combined therapeutic approaches in severe-to-critical COVID-19, contributing to the broader understanding of treatment strategies for complex infectious disease [2].

Keywords

NK cells, natural killer cells, NKG2A, NKG2C, adoptive immunotherapy, GMP manufacturing, immunology, COVID-19, translational medicine, biochemistry, molecular biology.

Introduction

Natural killer cells are an important component of the human immune system and have attracted substantial interest as candidates for cellular immunotherapy. Their therapeutic development requires reproducible manufacturing processes and careful consideration of biological variability. Research examining donor immunophenotypes can therefore help clarify factors associated with NK-cell production and downstream therapeutic applications [1].

Research Profile

The documented research profile is situated within Biochemistry, Genetics and Molecular Biology and intersects with immunology and translational biomedical research. The available record identifies two documents, while citation and h-index information has not been supplied. The publications demonstrate engagement with clinically relevant questions involving immune-cell therapies and severe infectious disease.

Research Contributions

  • Investigated donor NKG2A/NKG2C immunophenotypes in relation to GMP-compliant NK-cell manufacturing for adoptive immunotherapy [1].
  • Contributed to research evaluating rationales for combined therapies in severe-to-critical COVID-19 patients [2].
  • Connected laboratory immunology with translational considerations relevant to cellular therapy and clinical treatment strategies.

Publications

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, August 2026.[1].

Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology, September 11, 2023. [2].

Research Impact

The research addresses practical and clinically relevant questions in contemporary biomedical science. Work on GMP-compliant NK-cell manufacturing is particularly relevant to the translation of immune-cell research into standardized therapeutic products, while the COVID-19 publication contributes to the evidence base surrounding combination treatment strategies [1] [2].

Award Suitability

Rut Meseguer Naturil’s documented publications provide evidence of research activity spanning immune-cell biology, cellular therapy manufacturing, and clinical immunology. The combination of methodological and translational themes is relevant to the Best Researcher Award, particularly within the stated Biochemistry, Genetics and Molecular Biology subject area. Award assessment should consider the complete research record, including independently verifiable publications, scholarly impact, innovation, and broader contributions.

Conclusion

The available record presents Rut Meseguer Naturil as a researcher contributing to biomedical topics with relevance to immunotherapy and infectious disease. The documented studies provide a scholarly basis for recognition in the Best Researcher Award category, while further evaluation of the complete publication and impact record would provide a more comprehensive assessment.

References

  1. Meseguer Naturil, R., et al. (2026). Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, 18(17), 2732.
    https://doi.org/10.3390/cancers18172732
  2. Frontiers in Immunology. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology. PMID: 37767093; PMCID: PMC10520558.
    https://doi.org/10.3389/fimmu.2023.1232472
  3. MDPI. (2026). Cancers, Volume 18, Issue 17, Article 2732. Multidisciplinary Digital Publishing Institute.
    https://www.mdpi.com/2072-6694/18/17/2732
  4. Europe PMC. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Europe PMC record, PMCID: PMC10520558.
    https://europepmc.org/article/pmc/PMC10520558
  5. ORCID. (n.d.). Rut Meseguer Naturil — ORCID record. ORCID iD: 0000-0003-4376-5997.
    https://orcid.org/0000-0003-4376-5997
  6. International Academic Excellence Awards. (n.d.). Academic Excellence Awards. Award program website.
    https://academicexcellenceawards.com/

Sk Shehan Hossain | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

Published on by Academic Excellence

Young Scientist Award

Sk Shehan Hossain
Regional Institute of Biotechnology, India

Sk Shehan Hossain
Affiliation Regional Institute of Biotechnology
Country India
Documents 3
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0009-0004-7544-4607

Sk Shehan Hossain is an emerging researcher affiliated with the Regional Institute of Biotechnology, India. His scholarly activities are centered on microbiology, molecular biology, bioinformatics, and computational approaches in biological sciences. Through a combination of molecular characterization and in silico investigations, he has contributed to the documentation of microbial genetic resources and the exploration of biologically active compounds. His research profile demonstrates early-stage scientific productivity supported by publicly accessible datasets and preprint dissemination platforms.[1][3]

Abstract

This article presents an overview of the research profile of Sk Shehan Hossain in the context of the Young Scientist Award. His work includes microbial genetic identification through 16S ribosomal RNA sequencing and computational evaluation of naturally occurring compounds with potential biomedical relevance. The combination of laboratory-supported microbial studies and bioinformatics-based investigations reflects an interdisciplinary approach aligned with contemporary life science research.[2][3]

Keywords

Microbiology, Molecular Biology, Bacillus Species, 16S rRNA Sequencing, Bioinformatics, Computational Biology, Acetylcholinesterase Inhibitor, Biotechnology.

Introduction

Modern biotechnology increasingly integrates experimental and computational methodologies to address biological questions. Researchers working in this domain contribute to microbial characterization, genomic documentation, and the identification of bioactive compounds. Sk Shehan Hossain’s recent works reflect these trends through publicly archived sequence records and computational studies examining therapeutic potential in natural products.[2][3]

Research Profile

The research activities of Sk Shehan Hossain focus on biological characterization, microbial taxonomy, and computational analysis of biologically significant compounds. His profile demonstrates engagement with open scientific repositories and the dissemination of research findings through internationally accessible platforms. The available publications indicate a commitment to generating foundational scientific knowledge within biotechnology and molecular biology.[1]

Research Contributions

  • Documentation of Bacillus cereus strain AKANKSHYAYTB through 16S rRNA gene sequence submission.
  • Identification and reporting of Bacillus safensis strain BISAMLANWB genetic sequence data.
  • Computational evaluation of suaveolic acid as a potential acetylcholinesterase inhibitor.
  • Promotion of open scientific data accessibility through recognized repositories.

Publications

  1. Bacillus cereus strain AKANKSHYAYTB 16S ribosomal RNA gene, partial sequence (NCBI GenBank, 2026).
  2. Bacillus safensis strain BISAMLANWB 16S ribosomal RNA gene, partial sequence (NCBI GenBank, 2026).
  3. In Silico Investigation of Suaveolic Acid from Mesosphaerum suaveolens as an Acetylcholinesterase Inhibitor (Preprint, 2026).

Research Impact

The documented outputs contribute to publicly available scientific resources used by researchers in microbiology and biotechnology. Sequence submissions enrich genomic databases, while computational investigations provide preliminary insights that may support future experimental validation. Such contributions are valuable for advancing reproducibility, accessibility, and collaborative research within the life sciences.[2][3]

Award Suitability

The Young Scientist Award recognizes emerging researchers who demonstrate scientific promise and meaningful scholarly engagement. Based on the available record, Sk Shehan Hossain has established an early research portfolio encompassing molecular biology, microbial genetics, and computational biotechnology. His documented contributions and commitment to open scientific dissemination align with the objectives commonly associated with early-career research recognition programs.[4]

Conclusion

Sk Shehan Hossain represents a developing researcher whose work integrates microbial characterization and computational biological analysis. Through sequence database contributions and bioinformatics-based investigations, he has demonstrated engagement with contemporary scientific methodologies. His academic activities reflect the characteristics of an emerging scientist contributing to biotechnology and molecular biology research.

References

  1. Elsevier. (n.d.). ORCID author details: Sk Shehan Hossain.
  2. NCBI GenBank. (2026). Bacillus cereus strain AKANKSHYAYTB 16S ribosomal RNA gene, partial sequence.
    https://www.ncbi.nlm.nih.gov/nuccore/PZ619927
  3. Zenodo. (2026). In Silico Investigation of Suaveolic Acid from Mesosphaerum suaveolens as an Acetylcholinesterase Inhibitor.
    https://doi.org/10.5281/ZENODO.18837832
  4. International Academic Excellence Awards. (n.d.). Award recognition framework and evaluation criteria.
    academicexcellenceawards.com
  5. NCBI GenBank. (2026). Bacillus safensis strain BISAMLANWB 16S ribosomal RNA gene, partial sequence.
    https://www.ncbi.nlm.nih.gov/nuccore/PZ619164.1/